By Chris Kuo

Alphatec Holdings shares plummeted after the company lowered its full-year revenue outlook.

Shares of the medical technology company dropped 32% to $6.97. The shares plunged to a new 52-week low of $6.85 on Wednesday.

On Tuesday afternoon, Alphatec lowered its full-year revenue outlook amid declining sales of its EOS imaging systems. It now expects full-year revenue of about $882 million, compared with previous guidance for about $890 million.

Alphatec narrowed its first-quarter loss to $33.9 million, or 22 cents a share, from a loss of $51.9 million, or 35 cents a share, a year earlier. Analysts polled by FactSet expected a loss of 19 cents a share.

Revenue rose to $192.1 million from $169.2 million a year earlier. Analysts were expecting revenue of $197.5 million.

Sales of the company's EOS imaging systems were $14 million in the quarter, down $3 million year-over-year, Chief Financial Officer J. Todd Koning said in an earnings call. Revenue per case declined about 3% year over year, Koning said.

(END) Dow Jones Newswires

May 06, 2026 13:02 ET (17:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.